Dalton Price

A 20-year-old working to change the international health landscape

My name is Dalton Price, and I am a first-generation college student from Central Florida. I am presently an undergraduate student at Cornell University with studies in anthropology and infectious disease biology. Previously being recognized as a Coca-Cola Scholar, Jack Kent Cooke Scholar, Elks Scholar, Future Global Leader, and CAIR Champion of Justice, I am fortunate to have incredible support systems despite my humble beginnings. One of the most frightening yet galvanizing characteristics of our interconnected society is the threat of infectious diseases: humanity is perpetually at the brink of a global pandemic that can kill millions of people, more than any war in history, and we often don’t even know it. As I write this today, 31 August 2018, we currently battle Middle Eastern Respiratory Virus in England, the tenth Ebola outbreak in the Democratic Republic of the Congo, yellow fever in the Congo Republic, surging sexually-transmitted disease rates in the United States, African swine fever in China, and the largest cholera outbreak in recorded human history in Yemen. This excludes ongoing struggles with HIV, Zika, influenza, measles, antibiotic resistance, and bioterrorism, as well as the many other outbreaks that don’t reach public view. Consequently, I search for new solutions in the global health security space every day — whether it be through blockchain technology, improved global governance, or community-health models. Pandemic preparedness warrants concerted efforts among various stakeholders, including corporations, NGOs, governments, research institutions, and many more. Therefore, I have worked with many groups in order to develop a multisectoral understanding: patient advocacy and policy with The diaTribe Foundation, youth empowerment with YouResearch and the World Economic Forum, biotechnology and intellectual property with The Microbiome Coalition, public-health strategy and Medicaid finance with Aetna, biomedical and economics research at three academic institutions, clinical work at Halifax Medical Center, and antimicrobial resistance with the World Health Organization in Egypt. My most recent endeavor is a book about the U.S. healthcare system, which will be published in 2019.